{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:37:35Z","timestamp":1787020655109,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T00:00:00Z","timestamp":1551830400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"CCA_Huijgens Program, Amsterdam"},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["016.Veni.171.090"],"award-info":[{"award-number":["016.Veni.171.090"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Microb Cell Fact"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12934-019-1093-1","type":"journal-article","created":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T06:04:42Z","timestamp":1551852282000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Optimization of secretion and surface localization of heterologous OVA protein in mycobacteria by using LipY as a carrier"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9252-034X","authenticated-orcid":false,"given":"Maroeska J.","family":"Burggraaf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis S.","family":"Ates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Speer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"van der Kuij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coen","family":"Kuijl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8347-6511","authenticated-orcid":false,"given":"Wilbert","family":"Bitter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,6]]},"reference":[{"key":"1093_CR1","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1084\/jem.178.6.2243","volume":"178","author":"AM Cooper","year":"1993","unstructured":"Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med. 1993;178:2243\u20137.","journal-title":"J Exp Med"},{"key":"1093_CR2","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","volume":"178","author":"JL Flynn","year":"1993","unstructured":"Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon 7 in resistance to Mycobacterium tuberculosis infection. J Exp Med. 1993;178:2249\u201354.","journal-title":"J Exp Med"},{"key":"1093_CR3","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/trstmh\/trw016","volume":"110","author":"HA Fletcher","year":"2016","unstructured":"Fletcher HA, Schrager L. TB vaccine development and the End TB Strategy: importance and current status. Trans R Soc Trop Med Hyg. 2016;110:212\u20138.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1093_CR4","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1016\/j.celrep.2017.02.057","volume":"18","author":"MI Groschel","year":"2017","unstructured":"Groschel MI, Sayes F, Shin SJ, Frigui W, Pawlik A, Orgeur M, Canetti R, Honore N, Simeone R, van der Werf TS, et al. Recombinant BCG expressing ESX-1 of Mycobacterium marinum combines low virulence with cytosolic immune signaling and improved TB protection. Cell Rep. 2017;18:2752\u201365.","journal-title":"Cell Rep"},{"key":"1093_CR5","doi-asserted-by":"crossref","first-page":"6495","DOI":"10.1016\/j.vaccine.2009.08.044","volume":"27","author":"RG Bastos","year":"2009","unstructured":"Bastos RG, Borsuk S, Seixas FK, Dellagostin OA. Recombinant Mycobacterium bovis BCG. Vaccine. 2009;27:6495\u2013503.","journal-title":"Vaccine"},{"key":"1093_CR6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.tube.2004.10.004","volume":"85","author":"M Castanon-Arreola","year":"2005","unstructured":"Castanon-Arreola M, Lopez-Vidal Y, Espitia-Pinzon C, Hernandez-Pando R. A new vaccine against tuberculosis shows greater protection in a mouse model with progressive pulmonary tuberculosis. Tuberculosis. 2005;85:115\u201326.","journal-title":"Tuberculosis"},{"key":"1093_CR7","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.micinf.2005.04.002","volume":"7","author":"MA Horwitz","year":"2005","unstructured":"Horwitz MA. Recombinant BCG expressing Mycobacterium tuberculosis major extracellular proteins. Microbes Infect. 2005;7:947\u201354.","journal-title":"Microbes Infect"},{"key":"1093_CR8","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1016\/j.vaccine.2013.10.015","volume":"31","author":"Q Yu","year":"2013","unstructured":"Yu Q, Huang X, Gong P, Zhang Q, Li J, Zhang G, Yang J, Li H, Wang N, Zhang X. Protective immunity induced by a recombinant BCG vaccine encoding the cyclophilin gene of Toxoplasma gondii. Vaccine. 2013;31:6065\u201371.","journal-title":"Vaccine"},{"key":"1093_CR9","doi-asserted-by":"crossref","first-page":"20822","DOI":"10.1073\/pnas.0806244105","volume":"105","author":"SM Bueno","year":"2008","unstructured":"Bueno SM, Gonzalez PA, Cautivo KM, Mora JE, Leiva ED, Tobar HE, Fennelly GJ, Eugenin EA, Jacobs WR Jr, Riedel CA, Kalergis AM. Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG. Proc Natl Acad Sci USA. 2008;105:20822\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1093_CR10","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.micinf.2007.10.010","volume":"10","author":"IP Nascimento","year":"2008","unstructured":"Nascimento IP, Dias WO, Quintilio W, Christ AP, Moraes JF, Vancetto MD, Ribeiro-Dos-Santos G, Raw I, Leite LC. Neonatal immunization with a single dose of recombinant BCG expressing subunit S1 from pertussis toxin induces complete protection against Bordetella pertussis intracerebral challenge. Microbes Infect. 2008;10:198\u2013202.","journal-title":"Microbes Infect"},{"key":"1093_CR11","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.vaccine.2003.08.017","volume":"22","author":"RP Mazzantini","year":"2004","unstructured":"Mazzantini RP, Miyaji EN, Dias WO, Sakauchi D, Nascimento AL, Raw I, Winter N, Gicquel B, Rappuoli R, Leite LC. Adjuvant activity of Mycobacterium bovis BCG expressing CRM197 on the immune response induced by BCG expressing tetanus toxin fragment C. Vaccine. 2004;22:740\u20136.","journal-title":"Vaccine"},{"key":"1093_CR12","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1128\/IAI.72.6.3336-3343.2004","volume":"72","author":"PB Varaldo","year":"2004","unstructured":"Varaldo PB, Leite LC, Dias WO, Miyaji EN, Torres FI, Gebara VC, Armoa GR, Campos AS, Matos DC, Winter N, et al. Recombinant Mycobacterium bovis BCG expressing the Sm14 antigen of Schistosoma mansoni protects mice from cercarial challenge. Infect Immun. 2004;72:3336\u201343.","journal-title":"Infect Immun"},{"key":"1093_CR13","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1084\/jem.178.1.197","volume":"178","author":"CK Stover","year":"1993","unstructured":"Stover CK, Bansal GP, Hanson MS, Burlein JE, Palaszynski SR, Young JF, Koenig S, Young DB, Sadziene A, Barbour AG. Protective immunity elicited by recombinant Bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine. J Exp Med. 1993;178:197\u2013209.","journal-title":"J Exp Med"},{"key":"1093_CR14","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.4049\/jimmunol.150.7.3101","volume":"150","author":"Y Yasutomi","year":"1993","unstructured":"Yasutomi Y, Koenig S, Haun SS, Stover CK, Jackson RK, Conard P, Conley AJ, Emini EA, Fuerst TR, Letvin NL. Immunization with recombinant BCG-SIV elicits SIV-specific cytotoxic T lymphocytes in Rhesus monkeys. J Immunol. 1993;150:3101\u20137.","journal-title":"J Immunol."},{"key":"1093_CR15","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/351456a0","volume":"351","author":"CK Stover","year":"1991","unstructured":"Stover CK, de la Cruz VF, Fuerst TR, Burlein JE, Benson LA, Bennett LT, Bansal GP, Young JF, Lee MH, Hatfull GF, et al. New use of BCG for recombinant vaccines. Nature. 1991;351:456\u20139.","journal-title":"Nature"},{"key":"1093_CR16","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1007\/s00253-015-6495-3","volume":"99","author":"KR Begnini","year":"2015","unstructured":"Begnini KR, Buss JH, Collares T, Seixas FK. Recombinant Mycobacterium bovis BCG for immunotherapy in nonmuscle invasive bladder cancer. Appl Microbiol Biotechnol. 2015;99:3741\u201354.","journal-title":"Appl Microbiol Biotechnol"},{"key":"1093_CR17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0264-410X(02)00443-7","volume":"21","author":"RG Bastos","year":"2002","unstructured":"Bastos RG, Dellagostin OA, Barletta RG, Doster AR, Nelson E, Osorio FA. Construction and immunogenicity of recombinant Mycobacterium bovis BCG expressing GP5 and M protein of porcine reproductive respiratory syndrome virus. Vaccine. 2002;21:21\u20139.","journal-title":"Vaccine"},{"key":"1093_CR18","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1084\/jem.180.6.2277","volume":"180","author":"S Langermann","year":"1994","unstructured":"Langermann S, Palaszynski SR, Burlein JE, Koenig S, Hanson MS, Briles DE, Stover CK. Protective humoral response against pneumococcal infection in mice elicited by recombinant Bacille Calmette-Guerin vaccines expressing pneumococcal surface protein A. J Exp Med. 1994;180:2277\u201386.","journal-title":"J Exp Med"},{"key":"1093_CR19","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.intimp.2016.03.007","volume":"35","author":"A Takeuchi","year":"2016","unstructured":"Takeuchi A, Eto M, Tatsugami K, Shiota M, Yamada H, Kamiryo Y, Dejima T, Kashiwagi E, Kiyoshima K, Inokuchi J, et al. Antitumor activity of recombinant Bacille Calmette-Guerin secreting interleukin-15-Ag85B fusion protein against bladder cancer. Int Immunopharmacol. 2016;35:327\u201331.","journal-title":"Int Immunopharmacol"},{"key":"1093_CR20","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1086\/586902","volume":"197","author":"C Tang","year":"2008","unstructured":"Tang C, Yamada H, Shibata K, Maeda N, Yoshida S, Wajjwalku W, Ohara N, Yamada T, Kinoshita T, Yoshikai Y. Efficacy of recombinant Bacille Calmette-Guerin vaccine secreting interleukin-15\/antigen 85B fusion protein in providing protection against Mycobacterium tuberculosis. J Infect Dis. 2008;197:1263\u201374.","journal-title":"J Infect Dis"},{"key":"1093_CR21","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1128\/CVI.00407-06","volume":"14","author":"JS Yu","year":"2007","unstructured":"Yu JS, Peacock JW, Jacobs WR Jr, Frothingham R, Letvin NL, Liao HX, Haynes BF. Recombinant Mycobacterium bovis bacillus Calmette-Guerin elicits human immunodeficiency virus type 1 envelope-specific T lymphocytes at mucosal sites. Clin Vaccine Immunol. 2007;14:886\u201393.","journal-title":"Clin Vaccine Immunol"},{"key":"1093_CR22","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/S0264-410X(98)00350-8","volume":"17","author":"CM Hayward","year":"1999","unstructured":"Hayward CM, O\u2019Gaora P, Young DB, Griffin GE, Thole J, Hirst TR, Castello-Branco LR, Lewis DJ. Construction and murine immunogenicity of recombinant Bacille Calmette Guerin vaccines expressing the B subunit of Escherichia coli heat labile enterotoxin. Vaccine. 1999;17:1272\u201381.","journal-title":"Vaccine"},{"key":"1093_CR23","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.celrep.2018.03.125","volume":"23","author":"F Sayes","year":"2018","unstructured":"Sayes F, Blanc C, Ates LS, Deboosere N, Orgeur M, Le Chevalier F, Groschel MI, Frigui W, Song OR, Lo-Man R, et al. Multiplexed quantitation of intraphagocyte Mycobacterium tuberculosis secreted protein effectors. Cell Rep. 2018;23:1072\u201384.","journal-title":"Cell Rep"},{"key":"1093_CR24","doi-asserted-by":"crossref","first-page":"e1000507","DOI":"10.1371\/journal.ppat.1000507","volume":"5","author":"W Bitter","year":"2009","unstructured":"Bitter W, Houben EN, Bottai D, Brodin P, Brown EJ, Cox JS, Derbyshire K, Fortune SM, Gao LY, Liu J, et al. Systematic genetic nomenclature for type VII secretion systems. PLoS Pathog. 2009;5:e1000507.","journal-title":"PLoS Pathog"},{"key":"1093_CR25","doi-asserted-by":"crossref","first-page":"e1005190","DOI":"10.1371\/journal.pgen.1005190","volume":"11","author":"LS Ates","year":"2015","unstructured":"Ates LS, Ummels R, Commandeur S, van de Weerd R, Sparrius M, Weerdenburg E, Alber M, Kalscheuer R, Piersma SR, Abdallah AM, et al. Essential role of the ESX-5 secretion system in outer membrane permeability of pathogenic mycobacteria. PLoS Genet. 2015;11:e1005190.","journal-title":"PLoS Genet"},{"key":"1093_CR26","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2958.2009.06783.x","volume":"73","author":"AM Abdallah","year":"2009","unstructured":"Abdallah AM, Verboom T, Weerdenburg EM, Gey van Pittius NC, Mahasha PW, Jimenez C, Parra M, Cadieux N, Brennan MJ, Appelmelk BJ, Bitter W. PPE and PE_PGRS proteins of Mycobacterium marinum are transported via the type VII secretion system ESX-5. Mol Microbiol. 2009;73:329\u201340.","journal-title":"Mol Microbiol"},{"key":"1093_CR27","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.chom.2012.03.003","volume":"11","author":"F Sayes","year":"2012","unstructured":"Sayes F, Sun L, Di Luca M, Simeone R, Degaiffier N, Fiette L, Esin S, Brosch R, Bottai D, Leclerc C, Majlessi L. Strong immunogenicity and cross-reactivity of Mycobacterium tuberculosis ESX-5 type VII secretion: encoded PE-PPE proteins predicts vaccine potential. Cell Host Microbe. 2012;11:352\u201363.","journal-title":"Cell Host Microbe"},{"key":"1093_CR28","doi-asserted-by":"crossref","first-page":"19024","DOI":"10.1074\/jbc.M110.204966","volume":"286","author":"MH Daleke","year":"2011","unstructured":"Daleke MH, Cascioferro A, de Punder K, Ummels R, Abdallah AM, van der Wel N, Peters PJ, Luirink J, Manganelli R, Bitter W. Conserved Pro-Glu (PE) and Pro-Pro-Glu (PPE) protein domains target LipY lipases of pathogenic mycobacteria to the cell surface via the ESX-5 pathway. J Biol Chem. 2011;286:19024\u201334.","journal-title":"J Biol Chem"},{"key":"1093_CR29","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1074\/jbc.M505556200","volume":"281","author":"C Deb","year":"2006","unstructured":"Deb C, Daniel J, Sirakova TD, Abomoelak B, Dubey VS, Kolattukudy PE. A novel lipase belonging to the hormone-sensitive lipase family induced under starvation to utilize stored triacylglycerol in Mycobacterium tuberculosis. J Biol Chem. 2006;281:3866\u201375.","journal-title":"J Biol Chem"},{"key":"1093_CR30","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0966-842X(02)02335-1","volume":"10","author":"MJ Brennan","year":"2002","unstructured":"Brennan MJ, Delogu G. The PE multigene family: a \u2018molecular mantra\u2019 for mycobacteria. Trends Microbiol. 2002;10:246\u20139.","journal-title":"Trends Microbiol"},{"key":"1093_CR31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1471-2148-6-95","volume":"6","author":"SL Sampson","year":"2006","unstructured":"Gey van Pittius NC, Sampson SL, Lee H, Kim Y, van Helden PD, Warren RM. Evolution and expansion of the Mycobacterium tuberculosis PE and PPE multigene families and their association with the duplication of the ESAT-6 (esx) gene cluster regions. BMC Evol Biol. 2006;6:95.","journal-title":"BMC Evol Biol"},{"key":"1093_CR32","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1365-2958.2006.05409.x","volume":"62","author":"AM Abdallah","year":"2006","unstructured":"Abdallah AM, Verboom T, Hannes F, Safi M, Strong M, Eisenberg D, Musters RJ, Vandenbroucke-Grauls CM, Appelmelk BJ, Luirink J, Bitter W. A specific secretion system mediates PPE41 transport in pathogenic mycobacteria. Mol Microbiol. 2006;62:667\u201379.","journal-title":"Mol Microbiol"},{"key":"1093_CR33","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1111\/j.1365-2958.2007.06023.x","volume":"66","author":"A Cascioferro","year":"2007","unstructured":"Cascioferro A, Delogu G, Colone M, Sali M, Stringaro A, Arancia G, Fadda G, Palu G, Manganelli R. PE is a functional domain responsible for protein translocation and localization on mycobacterial cell wall. Mol Microbiol. 2007;66:1536\u201347.","journal-title":"Mol Microbiol"},{"key":"1093_CR34","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1365-2958.2004.04007.x","volume":"52","author":"G Delogu","year":"2004","unstructured":"Delogu G, Pusceddu C, Bua A, Fadda G, Brennan MJ, Zanetti S. Rv1818c-encoded PE_PGRS protein of Mycobacterium tuberculosis is surface exposed and influences bacterial cell structure. Mol Microbiol. 2004;52:725\u201333.","journal-title":"Mol Microbiol"},{"key":"1093_CR35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1365-2958.2002.02813.x","volume":"44","author":"S Banu","year":"2002","unstructured":"Banu S, Honore N, Saint-Joanis B, Philpott D, Prevost MC, Cole ST. Are the PE-PGRS proteins of Mycobacterium tuberculosis variable surface antigens? Mol Microbiol. 2002;44:9\u201319.","journal-title":"Mol Microbiol"},{"key":"1093_CR36","doi-asserted-by":"crossref","first-page":"7326","DOI":"10.1128\/IAI.69.12.7326-7333.2001","volume":"69","author":"MJ Brennan","year":"2001","unstructured":"Brennan MJ, Delogu G, Chen Y, Bardarov S, Kriakov J, Alavi M, Jacobs WR Jr. Evidence that mycobacterial PE_PGRS proteins are cell surface constituents that influence interactions with other cells. Infect Immun. 2001;69:7326\u201333.","journal-title":"Infect Immun"},{"key":"1093_CR37","doi-asserted-by":"crossref","first-page":"e00394","DOI":"10.1128\/IAI.00394-18","volume":"86","author":"P Santucci","year":"2018","unstructured":"Santucci P, Diomand\u00e9 S, Poncin I, Alibaud L, Viljoen A, Kremer L, de Chastellier C, Canaan S. Delineating the physiological roles of the PE and catalytic domain of LipY in lipid consumption in mycobacteria-infected macrophages. Infect Immun. 2018;86:e00394\u2013418.","journal-title":"Infect Immun."},{"key":"1093_CR38","doi-asserted-by":"crossref","first-page":"e27713","DOI":"10.1371\/journal.pone.0027713","volume":"6","author":"A Cascioferro","year":"2011","unstructured":"Cascioferro A, Daleke MH, Ventura M, Dona V, Delogu G, Palu G, Bitter W, Manganelli R. Functional dissection of the PE domain responsible for translocation of PE_PGRS33 across the mycobacterial cell wall. PLoS ONE. 2011;6:e27713.","journal-title":"PLoS ONE"},{"key":"1093_CR39","doi-asserted-by":"crossref","first-page":"e176","DOI":"10.1093\/nar\/gnh174","volume":"32","author":"BD Biles","year":"2004","unstructured":"Biles BD, Connolly BA. Low-fidelity Pyrococcus furiosus DNA polymerase mutants useful in error-prone PCR. Nucleic Acids Res. 2004;32:e176.","journal-title":"Nucleic Acids Res"},{"key":"1093_CR40","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nprot.2015.053","volume":"10","author":"LA Kelley","year":"2015","unstructured":"Kelley LA, Mezulis S, Yates CM, Wass MN, Sternberg MJ. The Phyre2 web portal for protein modeling, prediction and analysis. Nat Protoc. 2015;10:845\u201358.","journal-title":"Nat Protoc"},{"key":"1093_CR41","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0161-5890(90)90147-R","volume":"27","author":"G Johnsen","year":"1990","unstructured":"Johnsen G, Elsayed S. Antigenic and allergenic determinants of ovalbumin\u2013III. MHC Ia-binding peptide (OA 323\u2013339) interacts with human and rabbit specific antibodies. Mol Immunol. 1990;27:821\u20137.","journal-title":"Mol Immunol."},{"key":"1093_CR42","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1002\/eji.1830211136","volume":"21","author":"O R\u00f6tzke","year":"1991","unstructured":"R\u00f6tzke O, Falk K, Stevanovic S, Jung G, Walden P, Rammensee H. Exact prediction of a natural T cell epitope. Eur J Immunol. 1991;21:2891\u20134.","journal-title":"Eur J Immunol"},{"key":"1093_CR43","doi-asserted-by":"crossref","first-page":"e1007139","DOI":"10.1371\/journal.ppat.1007139","volume":"14","author":"LS Ates","year":"2018","unstructured":"Ates LS, Sayes F, Frigui W, Ummels R, Damen MPM, Bottai D, Behr MA, van Heijst JWJ, Bitter W, Majlessi L, Brosch R. RD5-mediated lack of PE_PGRS and PPE-MPTR export in BCG vaccine strains results in strong reduction of antigenic repertoire but little impact on protection. PLoS Pathog. 2018;14:e1007139.","journal-title":"PLoS Pathog."},{"key":"1093_CR44","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1128\/IAI.74.4.2128-2137.2006","volume":"74","author":"L Majlessi","year":"2006","unstructured":"Majlessi L, Simsova M, Jarvis Z, Brodin P, Rojas M, Bauche C, Nouz\u00e9 C, Ladant D, Cole ST, Sebo P, Leclerc C. An increase in antimicrobial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against Tuberculosis. Infect Immun. 2006;74:2128\u201337.","journal-title":"Infect Immun"},{"key":"1093_CR45","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.15252\/embr.201642943","volume":"17","author":"S Melnikov","year":"2016","unstructured":"Melnikov S, Mailliot J, Rigger L, Neuner S, Shin BS, Yusupova G, Dever TE, Micura R, Yusupov M. Molecular insights into protein synthesis with proline residues. EMBO Rep. 2016;17:1776\u201384.","journal-title":"EMBO Rep"},{"key":"1093_CR46","doi-asserted-by":"crossref","first-page":"e1005696","DOI":"10.1371\/journal.ppat.1005696","volume":"12","author":"LS Ates","year":"2016","unstructured":"Ates LS, van der Woude AD, Bestebroer J, van Stempvoort G, Musters RJ, Garcia-Vallejo JJ, Picavet DI, Weerd R, Maletta M, Kuijl CP, et al. The ESX-5 system of pathogenic mycobacteria is involved in capsule integrity and virulence through its substrate PPE10. PLoS Pathog. 2016;12:e1005696.","journal-title":"PLoS Pathog"},{"key":"1093_CR47","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0022-2836(88)90641-9","volume":"201","author":"DJT Barlow","year":"1988","unstructured":"Barlow DJT, Thornton JM. Helix geometry in proteins. J Mol Biol. 1988;201:601\u201319.","journal-title":"J Mol Biol."},{"key":"1093_CR48","doi-asserted-by":"crossref","first-page":"17047","DOI":"10.1038\/nmicrobiol.2017.47","volume":"2","author":"KS Beckham","year":"2017","unstructured":"Beckham KS, Ciccarelli L, Bunduc CM, Mertens HD, Ummels R, Lugmayr W, Mayr J, Rettel M, Savitski MM, Svergun DI, et al. Structure of the mycobacterial ESX-5 type VII secretion system membrane complex by single-particle analysis. Nat Microbiol. 2017;2:17047.","journal-title":"Nat Microbiol"},{"key":"1093_CR49","doi-asserted-by":"crossref","first-page":"e0135447","DOI":"10.1371\/journal.pone.0135447","volume":"10","author":"CK Garrett","year":"2015","unstructured":"Garrett CK, Broadwell LJ, Hayne CK, Neher SB. Modulation of the activity of Mycobacterium tuberculosis LipY by its PE domain. PLoS ONE. 2015;10:e0135447.","journal-title":"PLoS ONE"},{"key":"1093_CR50","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1128\/IAI.00410-07","volume":"76","author":"KC Mishra","year":"2008","unstructured":"Mishra KC, de Chastellier C, Narayana Y, Bifani P, Brown AK, Besra GS, Katoch VM, Joshi B, Balaji KN, Kremer L. Functional role of the PE domain and immunogenicity of the Mycobacterium tuberculosis triacylglycerol hydrolase LipY. Infect Immun. 2008;76:127\u201340.","journal-title":"Infect Immun"},{"key":"1093_CR51","doi-asserted-by":"crossref","first-page":"e1000794","DOI":"10.1371\/journal.ppat.1000794","volume":"6","author":"M Sani","year":"2010","unstructured":"Sani M, Houben EN, Geurtsen J, Pierson J, de Punder K, van Zon M, Wever B, Piersma SR, Jimenez CR, Daffe M, et al. Direct visualization by cryo-EM of the mycobacterial capsular layer: a labile structure containing ESX-1-secreted proteins. PLoS Pathog. 2010;6:e1000794.","journal-title":"PLoS Pathog"}],"container-title":["Microbial Cell Factories"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12934-019-1093-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12934-019-1093-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12934-019-1093-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T08:13:55Z","timestamp":1721031235000},"score":1,"resource":{"primary":{"URL":"https:\/\/microbialcellfactories.biomedcentral.com\/articles\/10.1186\/s12934-019-1093-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,6]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1093"],"URL":"https:\/\/doi.org\/10.1186\/s12934-019-1093-1","relation":{},"ISSN":["1475-2859"],"issn-type":[{"value":"1475-2859","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,6]]},"assertion":[{"value":"26 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"44"}}